Caption Management, LLC Intercept Pharmaceuticals, Inc. Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $2.54 Million - $4.1 Million	208,000 New	208,000 $2.9 Million
Q2 2022 Aug 15, 2022	SELL	$11.23 - $19.59 $1.24 Million - $2.17 Million	-110,600 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$13.37 - $17.79 $1.18 Million - $1.57 Million	88,000 Added 389.38%	110,600 $1.8 Million
Q4 2021 Feb 11, 2022	BUY	$14.28 - $19.53 $94,248 - $128,898	6,600 Added 41.25%	22,600 $368,000
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $939,040 - $1.29 Million	16,000 New	16,000 $1.06 Million
Q2 2019 Aug 13, 2019	SELL	$77.77 - $120.68 $2.71 Million - $4.21 Million	-34,900 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $3.2 Million - $4.21 Million	34,900 New	34,900 $3.9 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.